Division of Health and Clinical Data Program for Promoting Platform of Genomics based Drug Discovery

Outline

Key Fields Cancer, Life style disease (Diabetes, Hypertension etc.), Neurological and Psychiatric disorders, Aging and Dementia, Intractable and rare diseases, Child health and development, other, Health and Clinical Data Project, Japan Genomic Medicine Program(1st)
program year 04/01/15-
R&D phase Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study, Clinical Study, None
Contact
Division of Health and Clinical Data, Department of Data utilization and Life Course Research and Health and Development Program for Promoting Platform of Genomics based Drug Discovery SASAMATA Masao, KAMI Daisuke, KATAYAMA Katsuhiko, INOUE Takumi, HIKICHI Satomi, TAKAI Takako
Address: 22F Yomiuri Shimbun Bldg. 1-7-1 Otemachi, Chiyoda-ku, Tokyo 100-0004 Japan
TEL: +81-3-6870-2228
E-mail: genomic-medicine”AT”amed.go.jp

Overview

This project promotes basic research with a view to the practical implementation of genomic medicine, such as screening for causative genes by means of disease genome analysis and their functional evaluation, as well as validation studies with a view to their clinical application, and is also encouraging the research necessary to resolve the ethical, legal, and social issues posed by the provision of genomic therapy and to establish a training system for medical professionals.

Management and Evaluation Framework

PS (Program Supervisor)
  • YOSHIDA Teruhiko, M.D., Staff Physician, Department of Genetic Medicine and Services, National Cancer Center Hospital
PO (Program Officer)
  • ISHIKAWA Shumpei, M.D., Ph.D., Professor, Department of Preventive Medicine, Graduate School of Medicine, The University of Tokyo
  • NAKAGAWA Hidewaki, M.D., Ph.D., Team Director, RIKEN Center for Integrative Medical Sciences
  • YAMANO Yoshihisa, M.D., Ph.D., Professor & Chair, Department of Neurology

Last updated 06/06/25